Methicillin Resistant Staphylococcus Aureus (MRSA

1955 Words4 Pages

Stop Getting Sick at the Hospital:

Preventing the Spread of Methicillin Resistant Staphylococcus aureus (MRSA) in U.S. Hospitals

Information/Preliminary Issues

Methicillin Resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that is resistant to treatment by typical antibiotics. The most common kind is hospital-acquired (HAI), nosocomial, or healthcare-associated MRSA (HA-MRSA). People who undergo invasive medical procedures, who have compromised immune systems, or are being treated in patient care settings are most at risk for this infection. (CDC 2013)

The first observed cases of HA-MRSA occurred in the 1960’s. Since then, the overall proportion of staph bacteria that are methicillin resistant has increased over two-fold since 1992. (CDC 2013) In 2005, a conservative estimate of hospital patients that developed cases of invasive MRSA was close to 100,000; the number of fatalities was 20,000 deaths. The majority, or at least 65% of health care associated infections is attributed to MRSA. The mortality for hospital blood stream infections such as MRSA is 25% (Klevens et. al 2007).

The scope and magnitude of the explosive rise of HA-MRSA affects not only U.S. health care system but U.S. society as a whole. On the individual level, MRSA infections are correlated with greater lengths of hospital stay, higher mortality, and increased costs. Isolation from treatment of MRSA has been reported to be associated reduced frequency of visits by attending physicians and nurses, anxious and depressed patients, and more bedsores and falls. For health care providers, the treatment of infections of antibiotic resistant infections such as MRSA will have serious resounding economic impact: treatments costly due to...

... middle of paper ...

..., Petit, S., Gershman, K., Ray, S., & Active

Bacterial Core surveillance (ABCs) MRSA Investigators. (2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Jama, 298(15), 1763-1771.

Pittet, D., Hugonnet, S., Harbarth, S., Mourouga, P., Sauvan, V., Touveneau, S., & Perneger, T.

V. (2000). Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. The Lancet, 356(9238), 1307-1312.

Rosner, A. J., Becker, D. L., Wong, A. H., Miller, E., & Conly, J. M. (2004). The costs and consequences

of methicillin-resistant Staphylococcus aureus infection treatments in Canada. The Canadian ournal of Infectious Diseases & Medical Microbiology, 15(4), 213.

Wenzel, R. P., Bearman, G., & Edmond, M. B. (2008). Screening for MRSA: a flawed hospital

infection control intervention. Screening, 29(11), 1012-1018.

More about Methicillin Resistant Staphylococcus Aureus (MRSA

Open Document